NCT05353621 (SimStress) is a clinical trial of VAS reported Stress in Stress, Professional, sponsored by University Hospital, Grenoble.

Who is sponsoring NCT05353621?

NCT05353621 is sponsored by University Hospital, Grenoble.

What drugs are being tested in NCT05353621?

Interventions in NCT05353621: VAS reported Stress.

What condition does NCT05353621 study?

NCT05353621 studies Stress, Professional, Resilience, Anaesthesiology, Simulation.

Is NCT05353621 still recruiting?

NCT05353621 is currently completed. Last updated 2 December 2022.

Last reviewed 2022-12-02 · How we verify

NCT05353621: SimStress

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Resilience and Acute Stress in Simulation

Completed Last updated 2 December 2022

What this trial tests

trial testing VAS reported Stress in Stress, Professional in 79 participants. Completed in 15 November 2022.

Timeline

18 May 2022

Primary endpoint
4 October 2022

15 November 2022

Quick facts

Lead sponsor	University Hospital, Grenoble
Status	Completed
Study type	OBSERVATIONAL
Enrollment	79
Start date	18 May 2022
Primary completion	4 October 2022
Estimated completion	15 November 2022
Sites	1 location across France

Drugs / interventions tested

VAS reported Stress

Conditions studied

Stress, Professional — all drugs for Stress, Professional →
Resilience — all drugs for Resilience →
Anaesthesiology — all drugs for Anaesthesiology →
Simulation — all drugs for Simulation →

Sponsor

University Hospital, Grenoble

Who can join

Eligibility, any sex, with Stress, Professional or Resilience. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective is to study an association between the resilience developed by anesthesia professionals and the level of acute stress during a simulation session.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Grenoble trials

Trials by the same sponsor.

NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05353621 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
Last refreshed: 2 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05353621.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing